APA (7th ed.) Citation

J, K., LS, S., K, K., N, W., M, O., C, M., . . . S, S. (2023). Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma. Hematological oncology, 41(3), 453. https://doi.org/10.1002/hon.3123

Chicago Style (17th ed.) Citation

J, Kauer, Sester LS, Kriegsmann K, Weinhold N, Ober M, Müller-Tidow C, Goldschmidt H, Raab MS, and Sauer S. "Cyclophosphamide Etoposide Dexamethasone as Salvage and Bridging Therapy in Relapsed Refractory and Extramedullary Multiple Myeloma." Hematological Oncology 41, no. 3 (2023): 453. https://doi.org/10.1002/hon.3123.

MLA (9th ed.) Citation

J, Kauer, et al. "Cyclophosphamide Etoposide Dexamethasone as Salvage and Bridging Therapy in Relapsed Refractory and Extramedullary Multiple Myeloma." Hematological Oncology, vol. 41, no. 3, 2023, p. 453, https://doi.org/10.1002/hon.3123.